EGFR and non-small cell lung carcinoma: This retrospective study in Galicia (Spain) evaluated the clinical characteristics, treatment response, and survival of patients with NSCLC and EGFR Ex20Ins.<h4>Methods</h4>Data from patients diagnosed between 2013 and 2023, confirmed by next-generation sequencing (NGS) or polymerase chain reaction (PCR), were included.